Staphylokinase-specific cell-mediated immunity in humans

Journal of Immunology

Volumn 168, Issue 1, 2002, Pages 155-161

  Warmerdam, P A M ^a   Vanderlick, K ^a   Vandervoort, P ^a   De Smedt, H ^a   Plaisance, S ^a   De Maeyer, M ^a   Collen, D ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; NEUTRALIZING ANTIBODY; STAPHYLOKINASE;

ALLELE; ANTIGENICITY; ARTICLE; BLOOD CLOT LYSIS; CELL CLONE; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0036134883     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.1.155     Document Type: Article

References (36)

1. Staphylokinase: An activator of plasma protease
2. Cloning and expression in Escherichia coli, Bacillus subtilis, and Streptococcus sanguis of a gene for staphylokinase: A bacterial plasminogen activator
3. Primary structure and gene structure of staphylokinase
4. Staphylokinase: A potent, uniquely fibrin-selective thrombolytic agent
5. Coronary thrombolysis with recombinant staphylokinase in patients with evolving myocardial infarction
6. Thrombolytic therapy of peripheral arterial occlusion with recombinant staphylokinase
7. A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction: The STAR Trial Group
8. Prevalence and induction of circulating antibodies against recombinant staphylokinase
9. On the immunogenicity of recombinant staphylokinase in patients and in animal models
10. Recombinant staphylokinase variants with altered immunoreactivity. III. Species variability of antibody binding patterns
11. High resolution mapping of the B cell epitopes of staphylokinase in humans using negative selection of a phage-displayed antigen library
12. Recombinant staphylokinase variants with altered immunoreactivity. II. Thrombolytic properties and antibody induction
13. Recombinant staphylokinase variants with altered immunoreactivity. IV. Identification of variants with reduced antibody induction but intact potency
14. Thymocyte selection: Not by TCR alone
15. Antibody humanization: A case of the "Emperor's new clothes"?
16. New insights and approaches regarding B- and T-cell epitopes in HIV vaccine design
17. Personal historical chronicle of six decades of basic and applied research in virology, immunology, and vaccinology
18. High yield production and purification of recombinant staphylokinase for thrombolytic therapy
19. Recombinant staphylokinase variants with altered immunoreactivity. I. Construction and characterization
20. + T cell epitopes with dedicated synthetic peptide libraries
21. Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization
22. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes
23. Antistreptokinase titres after intravenous streptokinase
24. Humoral and cellular immune responses up to 7.5 years after administration of streptokinase for acute myocardial infarction
25. A pilot study on bolus administration of recombinant staphylokinase for coronary artery thrombolysis
26. Use of the plasminogen activation system by microorganisms
27. Use of streptokinase as a recall antigen for lymphocyte proliferation testing in vitro
28. Staphylococcus aureus bacteriophages mediating the simultaneous lysogenic conversion of β-lysin, staphylokinase and enterotoxin A: Molecular mechanism of triple conversion
29. Isolation and characterization of natural and recombinant staphylokinase
30. Enterotoxin production by Staphylococcus aureus isolates from cases of septicaemia and from healthy carriers
31. Staphylococcus aureus in chronic and recurrent infections
32. A very high level of crossreactivity is an essential feature of the T-cell receptor
33. Molecular basis for recognition of an arthritic peptide and a foreign epitope on distinct MHC molecules by a single TCR
34. SYFPEITHI: Database for MHC ligands and peptide motifs
35. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices
36. The dead-end elimination theorem and its use in protein side-chain positioning